Literature DB >> 3157986

Changes in left ventricular anatomy during haemodialysis, continuous ambulatory peritoneal dialysis and after renal transplantation.

A Deligiannis, E Paschalidou, G Sakellariou, V Vargemezis, P Geleris, A Kontopoulos, M Papadimitriou.   

Abstract

The changes in left ventricular anatomy in 30 patients with end-stage renal disease and stable cardiac function, undergoing regular haemodialysis (10 patients), continuous ambulatory peritoneal dialysis (10 patients) and after successful renal transplantation (10 patients) were evaluated by M-mode echocardiography. Initially all had evidence of left ventricular hypertrophy and dilatation. Reevaluation after a mean follow-up of 22 months on each mode of treatment showed that in the haemodialysis group the left ventricular mass and volume were increased, while in continuous ambulatory peritoneal dialysis (CAPD) and, especially renal transplantation, the hypertrophy and dilatation were reversed. This improvement was probably due to a reduction of cardiac workload.

Entities:  

Mesh:

Year:  1985        PMID: 3157986

Source DB:  PubMed          Journal:  Proc Eur Dial Transplant Assoc Eur Ren Assoc


  4 in total

Review 1.  Epidemiology, pathophysiology, clinical characteristics and management of childhood cardiorenal syndrome.

Authors:  Wasiu A Olowu
Journal:  World J Nephrol       Date:  2012-02-06

Review 2.  Central and peripheral adaptations to physical training in patients with end-stage renal disease.

Authors:  E J Kouidi
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

3.  Correlative factors of left ventricular hypertrophy in end-stage renal disease.

Authors:  Y Dai; S J He; Y Yu; L Y Zhu; B Peng; J B Liu; S C Tang
Journal:  J Tongji Med Univ       Date:  1993

4.  The changes in cardiac dimensions and function in patients with end stage renal disease undergoing hemodialysis.

Authors:  Dong Won Lee; Yong Beom Kim; Seoung Jae An; Yoo Suck Jung; Ihm Soo Kwak; Yung Woo Shin; Ha Yeon Rha
Journal:  Korean J Intern Med       Date:  2002-06       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.